IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice

European Journal of Immunology

Volumn 47, Issue 12, 2017, Pages 2070-2079

  Kao, Daniela ^a   Lux, Anja ^a   Schaffert, Anja ^a   Lang, Roland ^b   Altmann, Friedrich ^c   Nimmerjahn, Falk ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Fc receptor; Glycosylation; Serum IgG subclass; Vaccination

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; T LYMPHOCYTE ANTIGEN; ANTIGEN; CARBOHYDRATE; GLYCOPEPTIDE; GLYCOSYLATED IGG; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANTIBODY GLYCOSYLATION; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; FEMALE; GLYCOSYLATION; IMMUNE RESPONSE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; STEADY STATE; VACCINATION; ANIMAL; ANTIBODY PRODUCTION; C57BL MOUSE; CHEMISTRY; IMMUNOLOGY; METABOLISM; PROCEDURES; T LYMPHOCYTE;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; FEMALE; GLYCOPEPTIDES; GLYCOSYLATION; IMMUNOGLOBULIN G; MASS SPECTROMETRY; MICE, INBRED C57BL; RECEPTORS, IGG; SUGARS; T-LYMPHOCYTES; VACCINATION;

EID: 85037581111     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201747208     Document Type: Article

References (55)

1. Glennie, M. J., French, R. R., Cragg, M. S. and Taylor, R. P., Mechanisms of killing by anti-CD20 monoclonal antibodies. Mol. Immunol. 2007. 44: 3823–3837.
2. Pincetic, A., Bournazos, S., DiLillo, D. J., Maamary, J., Wang, T. T., Dahan, R., Fiebiger, B. M. et al., Type I and type II Fc receptors regulate innate and adaptive immunity. Nat. Immunol. 2014. 15: 707–716.
3. Nimmerjahn, F., Gordan, S. and Lux, A., FcgammaR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities. Trends Immunol. 2015. 36: 325–336.
4. Beers, S. A., Chan, C. H., James, S., French, R. R., Attfield, K. E., Brennan, C. M., Ahuja, A. et al., Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation. Blood 2008. 112: 4170–4177.
5. Hamaguchi, Y., Xiu, Y., Komura, K., Nimmerjahn, F. and Tedder, T. F., Antibody isotype-specific engagement of Fc gamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. J. Exp. Med. 2006. 203: 743–753.
6. Kao, D., Danzer, H., Collin, M., Gross, A., Eichler, J., Stambuk, J., Lauc, G. et al., A monosaccharide residue is sufficient to maintain mouse and human IgG subclass activity and directs IgG effector functions to cellular Fc receptors. Cell Rep. 2015. 13: 2376–2385.
7. Nimmerjahn, F., Bruhns, P., Horiuchi, K. and Ravetch, J. V., FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 2005. 23: 41–51.
8. Nimmerjahn, F. and Ravetch, J. V., Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 2005. 310: 1510–1512.
9. Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N. and Dwek, R. A., Emerging principles for the therapeutic exploitation of glycosylation. Science 2014. 343: 1235681.
10. Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M. and Dwek, R. A., The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 2007. 25: 21–50.
11. Lund, J., Takahashi, N., Nakagawa, H., Goodall, M., Bentley, T., Hindley, S. A., Tyler, R. et al., Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. Mol. Immunol. 1993. 30: 741–748.
12. Maresch, D. and Altmann, F., Isotype-specific glycosylation analysis of mouse IgG by LC-MS. Proteomics 2016. 16: 1321–1330.
13. Dube, R., Rook, G. A., Steele, J., Brealey, R., Dwek, R., Rademacher, T. and Lennard-Jones, J., Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut 1990. 31: 431–434.
14. Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A. and Sim, R. B., Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1995. 1: 237–243.
15. Mehta, A. S., Long, R. E., Comunale, M. A., Wang, M., Rodemich, L., Krakover, J., Philip, R. et al., Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J. Virol. 2008. 82: 1259–1270.
16. Parekh, R., Isenberg, D., Rook, G., Roitt, I., Dwek, R. and Rademacher, T., A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J. Autoimmun. 1989. 2: 101–114.
17. Parekh, R., Roitt, I., Isenberg, D., Dwek, R. and Rademacher, T., Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 1988. 167: 1731–1736.
18. Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W. et al., Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985. 316: 452–457.
19. Parekh, R. B., Roitt, I. M., Isenberg, D. A., Dwek, R. A., Ansell, B. M. and Rademacher, T. W., Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988. 1: 966–969.
20. Rademacher, T. W., Williams, P. and Dwek, R. A., Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA 1994. 91: 6123–6127.
21. van de Geijn, F. E., Wuhrer, M., Selman, M. H., Willemsen, S. P., de Man, Y. A., Deelder, A. M., Hazes, J. M. et al., Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res. Ther. 2009. 11: R193.
22. Scherer, H. U., van der Woude, D., Ioan-Facsinay, A., el Bannoudi, H., Trouw, L. A., Wang, J., Haupl, T. et al., Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis. Rheum. 2010. 62: 1620–1629.
23. Scherer, H. U., Wang, J., Toes, R. E., van der Woude, D., Koeleman, C. A., de Boer, A. R., Huizinga, T. W. et al., Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum. Proteomics Clin. Appl. 2009. 3: 106–115.
24. Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C. A., Deelder, A., de Haas, M. and Vidarsson, G., Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J. Proteome Res. 2009. 8: 450–456.
25. Ferrara, C., Stuart, F., Sondermann, P., Brunker, P. and Umana, P., The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J. Biol. Chem. 2006. 281: 5032–5036.
26. Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K. et al., The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 2003. 278: 3466–3473.
27. Anthony, R. M., Kobayashi, T., Wermeling, F. and Ravetch, J. V., Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 2011. 475: 110–113.
28. Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C. and Ravetch, J. V., Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008. 320: 373–376.
29. Kaneko, Y., Nimmerjahn, F. and Ravetch, J. V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006. 313: 670–673.
30. Massoud, A. H., Yona, M., Xue, D., Chouiali, F., Alturaihi, H., Ablona, A., Mourad, W. et al., Dendritic cell immunoreceptor: A novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J. Allergy. Clin. Immunol. 2014. 133: 853–863 e855.
31. Schwab, I., Mihai, S., Seeling, M., Kasperkiewicz, M., Ludwig, R. and Nimmerjahn, F., Broad requirement for terminal sialic acid residues and FcgRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo. Eur. J. Immunol. 2014. 44: 1444–1453.
32. Schwab, I. and Nimmerjahn, F., Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat. Rev. Immunol. 2013. 13: 176–189.
33. Seite, J. F., Cornec, D., Renaudineau, Y., Youinou, P., Mageed, R. A. and Hillion, S., IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood 2010. 116: 1698–1704.
34. Schwab, I., Lux, A. and Nimmerjahn, F., Pathways responsible for human autoantibody and therapeutic intravenous IgG activity in humanized mice. Cell Rep. 2015. 13: 610–620.
35. Harre, U., Lang, S. C., Pfeifle, R., Rombouts, Y., Fruhbeisser, S., Amara, K., Bang, H. et al., Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat. Comm. 2015. 6: 6651.
36. Campbell, I. K., Miescher, S., Branch, D. R., Mott, P. J., Lazarus, A. H., Han, D., Maraskovsky, E. et al., Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. J. Immunol. 2014. 192: 5031–5038.
37. Leontyev, D., Katsman, Y., Ma, X. Z., Miescher, S., Kasermann, F. and Branch, D. R., Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin. Transfusion 2012. 52: 1799–1805.
38. Guhr, T., Bloem, J., Derksen, N. I., Wuhrer, M., Koenderman, A. H., Aalberse, R. C. and Rispens, T., Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia. PLoS One 2011. 6: e21246.
39. Karsten, C. M., Pandey, M. K., Figge, J. et al., Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat. Med. 2012. 18: 1401–1406.
40. Wang, J., Balog, C. I., Stavenhagen, K., Koeleman, C. A., Scherer, H. U., Selman, M. H., Deelder, A. M. et al., Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol. Cell. Proteomics 2011. 10: M110 004655.
41. Lauc, G., Huffman, J. E., Pucic, M., Zgaga, L., Adamczyk, B., Muzinic, A., Novokmet, M. et al., Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLos Genet. 2013. 9: e1003225.
42. Hess, C., Winkler, A., Lorenz, A. K., Holecska, V., Blanchard, V., Eiglmeier, S., Schoen, A. L. et al., T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 2013. 123: 3788–3796.
43. Oefner, C. M., Winkler, A., Hess, C., Lorenz, A. K., Holecska, V., Huxdorf, M., Schommartz, T. et al., Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J. Allergy. Clin. Immunol. 2012. 129: 1647–1655 e1613.
44. Nimmerjahn, F., Lux, A., Albert, H., Woigk, M., Lehmann, C., Dudziak, D., Smith, P. et al., FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. Proc. Natl. Acad. Sci. USA 2010. 107: 19396–19401.
45. Seeling, M., Hillenhoff, U., David, J. P., Schett, G., Tuckermann, J., Lux, A. and Nimmerjahn, F., Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc. Natl. Acad. Sci. USA 2013. 110: 10729–10734.
46. Wuhrer, M., Stam, J. C., van de Geijn, F. E., Koeleman, C. A., Verrips, C. T., Dolhain, R. J., Hokke, C. H. et al., Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 2007. 7: 4070–4081.
47. Lundstrom, S. L., Yang, H., Lyutvinskiy, Y., Rutishauser, D., Herukka, S. K., Soininen, H. and Zubarev, R. A., Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairment. J. Alzheimers Dis. 2014. 38: 567–579.
48. Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M., Boackle, S. A., Takahashi, K. et al., Arthritis critically dependent on innate immune system players. Immunity 2002. 16: 157–168.
49. de Haan, N., Reiding, K. R., Kristic, J., Hipgrave Ederveen, A. L., Lauc, G. and Wuhrer, M., The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains. Front Immunol. 2017. 8: 608.
50. Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N. and Raju, T. S., Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol. Immunol. 2007. 44: 1524–1534.
51. Ahmed, A. A., Giddens, J., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L. X. and Bjorkman, P. J., Structural characterization of anti-inflammatory immunoglobulin G Fc proteins. J. Mol. Biol. 2014. 426: 3166–3179.
52. Selman, M. H., de Jong, S. E., Soonawala, D., Kroon, F. P., Adegnika, A. A., Deelder, A. M., Hokke, C. H. et al., Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Mol. Cell. Proteomics 2012. 11: M111 014563.
53. Stadlmann, J., Pabst, M., Kolarich, D., Kunert, R. and Altmann, F., Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 2008. 8: 2858–2871.
54. Zhang, X., Asara, J. M., Adamec, J. and Ouzzani, M., Data preprocessing in liquid chromatography-mass spectrometry based proteomics. Bioinformatics 2005. 21: 4054–4059.
55. Pabst, M., Chang, M., Stadlmann, J. and Altmann, F., Glycan profiles of the 27 N-glycosylation sites of the HIV envelope protein CN54gp140. Biol. Chem. 2012. 393: 719–730.